文献速递临床生化质量管理与危急值

脂血指数在常规血检成人中识别严重富含甘油三酯脂蛋白紊乱的临床价值

Clinical utility of the lipemic index for identifying severe triglyceride-rich lipoprotein disorders in adults undergoing routine blood testing.
PubMed 文献 · Clin Chim Acta · 2026-09-19

本研究为横断面研究,纳入332,476份样本(71,768名患者),评估脂血指数(L-index)识别严重富含甘油三酯脂蛋白(TRL)紊乱的效用。L-index≥1者占0.8%,其中77%有血脂异常;这些血脂异常患者中35%符合严重TRL紊乱的生化筛查标准。L-index作为自动化指标可能有助于识别需进一步评估的患者。

要点

  • L-index≥1在常规血检成人中占0.8%,其中77%存在血脂异常。
  • L-index≥1且血脂异常者中35%符合严重TRL紊乱生化筛查标准。
  • L-index为自动化、无额外成本的指标,可辅助识别需进一步评估者。

核心结论

  • L-index升高患病率低,但L-index≥1且血脂异常者中约三分之一符合严重TRL紊乱的生化筛查标准。

研究设计与样本

  • 横断面研究,纳入所有有L-index结果的样本(除外儿科和ICU样本),共332,476份样本来自71,768名患者。
  • 对L-index≥1的患者检测血脂 panel 和apoB,排除接受静脉脂肪乳剂者后筛查严重TRL紊乱。

主要发现

  • 575名患者(0.8%)L-index≥1,其中441名(77%)有血脂异常。
  • 441名L-index≥1且血脂异常的患者中,154名(35%)符合严重TRL紊乱的生化筛查标准。
  • 20例进行PGGE检测,2例(10%)确认FD样表型。

关键数值与推荐

  • 严重高甘油三酯血症定义为TG>10 mmol/L。
  • FD样表型生化标准为TG≥2.0 mmol/L、TC≥5.2 mmol/L且non-HDL-C/apoB>3.69。
  • FD样表型通过聚丙烯酰胺梯度凝胶电泳(PGGE)评估。

临床怎么用

  • L-index可作为常规血检中无额外成本的自动化指标,提示需进一步血脂评估的患者。
  • 对L-index≥1者应检测血脂 panel 和apoB,以筛查严重高甘油三酯血症和FD样表型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The lipemic index (L-index) is an automated measure of plasma turbidity used for pre-analytical quality control in clinical chemistry. As turbidity often reflects accumulation of triglyceride-rich lipoproteins (TRL), elevated L-index values may indicate underlying hyperlipoproteinemias, including severe hypertriglyceridemia and familial dysbetalipoproteinemia (FD). These rare, underdiagnosed disorders can have severe clinical consequences such as pancreatitis and cardiovascular disease. OBJECTIVE: This study evaluated the clinical utility of the L-index for identifying severe TRL disorders in adults undergoing routine blood testing. METHODS: In this cross-sectional study, all samples with an L-index result were eligible, except pediatric and ICU samples. In patients with L-index ≥1, a lipid panel and apoB were measured in leftover material. After excluding patients receiving intravenous lipid emulsions, patients with dyslipidemia were screened for severe TRL disorders (severe hypertriglyceridemia [>10 mmol/L] or an FD-like phenotype [TG ≥2.0 mmol/L, TC ≥5.2 mmol/L and non-HDL-C/apoB >3.69]). FD-like phenotypes were assessed using polyacrylamide gradient gel electrophoresis (PGGE). RESULTS: Among 332,476 consecutive samples from 71,768 unique patients, 575 patients (0.8%) had L-index ≥1, of whom 441 (77%) had dyslipidemia. Among patients with L-index ≥1 and dyslipidemia, 154/441 (35%) met biochemical screening criteria for a severe TRL disorder. PGGE confirmed an FD-like phenotype in 2/20 (10%) cases. CONCLUSION: Although the prevalence of an elevated L-index was low, approximately one-third of patients with L-index ≥1 and dyslipidemia met biochemical screening criteria for a severe TRL disorder. As an automated measure available at no additional cost, the L-index may help identify patients warranting further evaluation, particularly for severe hypertriglyceridemia and potentially FD-like phenotypes.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Schuitema PCE, Kemperman H, Smits S, et al. Clinical utility of the lipemic index for identifying severe triglyceride-rich lipoprotein disorders in adults undergoing routine blood testing. Clin Chim Acta. 2026. PMID: 42763046. doi:10.1016/j.cca.2026.121351

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。